EXECUTION VERSION SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of January 31, 2024, between Kiora Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the...Securities Purchase Agreement • February 1st, 2024 • Kiora Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 1st, 2024 Company Industry Jurisdiction
ContractWarrant Agreement • February 1st, 2024 • Kiora Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledFebruary 1st, 2024 Company Industry
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...Pre-Funded Common Stock Purchase Warrant • February 1st, 2024 • Kiora Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledFebruary 1st, 2024 Company Industry
EXECUTION VERSION PLACEMENT AGENCY AGREEMENT January 31, 2024 Brian M. Strem, Ph.D. Chief Executive Officer Kiora Pharmaceuticals, Inc. 332 Encinitas, California 92024 Dear Dr. Strem: This agreement (the “Agreement”) constitutes the agreement between...Placement Agency Agreement • February 1st, 2024 • Kiora Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 1st, 2024 Company Industry Jurisdiction